US Spending $1.2 Billion on Merck’s COVID-19 Treatment Is a ‘Waste of Taxpayers’ Money’: Doctor

Posted on AllSides June 17th, 2021
From The Right

A critical care doctor has said it’s a waste of taxpayers’ money for the U.S. government to purchase drug company Merck’s anti-viral treatment for COVID-19, if it’s approved by the Food and Drug Administration (FDA).

Dr. Pierre Kory, president and chief medical officer of the Front Line COVID-19 Critical Care Alliance (FLCCC), said there’s no reason for the Biden administration to “enrich Merck for a drug, which has already been the source of a whistleblower complaint, and which has already failed in hospitalized patients” when ivermectin, a “low cost, safe, widely...

Read full story
Some content from this outlet may be limited or behind a paywall.

The Epoch Times

AllSides Media Bias Rating: Lean Right
AllSides Media Bias Rating: Lean Right
108213/84923
See full bias rating for The Epoch Times
Learn about media bias
https://www.theepochtimes.com/us-spending-1-2-billion-on-mercks-covid-19-treatment-is-a-waste-of-taxpayers-money-doctor_3861829.html

More News about Coronavirus from the Left, Center and Right

From the Left

From the Center

From the Right